Last updated on September 2020

Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera Hemodialysis Population

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: chronic renal insufficiency
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age> or equal to 18 years
  • Patients on hemodialysis or hemodiafiltration for at least 3 months
  • Patient treated monthly by Mircera for at least one month
  • Affiliate or enjoying a social security scheme
  • Patients who received oral and written information about the study, with no objection to the use of personal data and having signed an informed consent form and written

Exclusion Criteria:

  • Patient who refused to give his written consent to the study
  • Patients treated with another Erythropoiesis stimulating agent
  • Minor
  • Pregnant or breastfeeding women
  • Major under guardianship

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.